Dr. Tse observed multiple thyroid nodule ablation procedures at Sun Yat-sen University Cancer Center, gaining valuable insights into the precision and clinical efficacy of Baird Medical's MWA system. In addition to the procedural observations, Dr. Tse participated in academic discussions with Dr. Michael Mingzhao Xing, Professor Emeritus at the Johns Hopkins University School of Medicine. Together, they explored the latest advancements and clinical outcomes in thyroid nodule management. Dr. Tse's visit rein ...

Core Insights - Baird Medical is preparing for market entry by establishing partnerships with leading healthcare institutions to create distribution networks and training programs for microwave ablation (MWA) procedures [1][2] - The company specializes in minimally invasive procedures, particularly MWA, which utilizes targeted microwave energy for high precision and efficiency in treating thyroid nodules and tumors [2][3] - Baird Medical is committed to integrating AI-powered surgical robotic systems and innovative instruments into its offerings, aiming to enhance patient outcomes through advanced technology [3] Company Overview - Baird Medical focuses on minimally invasive diagnostics and treatments, with a mission to improve patient outcomes through precision technology [3] - The company is FDA 510(k)-certified and has deployed its solutions in over 30 prestigious hospitals and clinics in the United States, including Johns Hopkins Hospital and Weill Cornell Medicine [3] - Baird Medical is a market leader in China for thyroid microwave ablation devices and is expanding its commercial presence in over 20 countries worldwide [3]

NEW YORK, March 17, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company") has been honored with the "Most Valuable Investment Award" at the 10th China Medical Industry Innovation Competition with its revolutionary in-development product, the "AI Tumor Ablation Surgical Robot." This prestigious recognition marks a significant milestone in the advancement of AI and robotics integration that Baird Medical is developing in the medical field. AI & Robotics: ...

"This regulatory approval marks a significant step in our global strategic expansion and underscores our commitment to improving patient care with cutting-edge, minimally invasive technologies," said Haimei Wu, Chairwoman of Baird Medical.  "We look forward to collaborating with Indonesian healthcare providers and supporting them with innovative solutions that enhance precision, safety, and patient outcomes. Microwave ablation is a highly effective, minimally invasive procedure that uses targeted microwave ...

As a premier gathering for experts in interventional endocrinology, NASOIE serves as a platform for advancing minimally invasive treatments for thyroid and parathyroid disorders. The event convenes top-tier clinicians and researchers to explore the latest breakthroughs in treating thyroid nodules and cancer recurrences. Baird Medical's presence at NASOIE 2025 drew strong engagement, with numerous physicians visiting the booth to explore the latest advancements in MWA technology. Attendees participated in ha ...

The delegation included Dr. MD Mofazzal Sharif, Dr. Mohammad Rezaul Haque, Dr. Alamgir A.B.M., and Dr. Mohammad Jannatul Ferdous Rubel, who participated in a comprehensive training program designed to enhance their expertise in MWA techniques. The program's first day featured in-depth theoretical discussions and hands-on demonstrations at Baird Medical's state-of-the-art facility, providing participants with a deeper understanding of MWA applications in clinical practice. On the second day, the delegation c ...

Led by Dr. Jennifer Kuo, Director of the Interventional Endocrinology Program and Program Director of the Endocrine Surgery Fellowship at Columbia University's Department of Surgery, the two-day course provided in-depth instruction on MWA techniques, procedural safety, and clinical applications. The program attracted physicians from the United States and Mexico, including Dr. Hosai Todd-Hesham, an Otolaryngology specialist from Maryland ENT Associates, and Dr. Camilo González Velázquez, Associate Professor ...

Core Insights - Baird Medical showcased its minimally invasive microwave ablation (MWA) technology at NASIT 2025, generating significant interest and discussions among clinicians regarding future thyroid therapies [1][3] - Dr. Emad Kandil presented compelling case studies highlighting MWA as a safe and effective alternative to traditional thyroid surgery, emphasizing benefits such as reduced procedure times and improved patient outcomes [2] - The company aims to enhance treatment options through further research and strategic partnerships, reinforcing its commitment to innovation in patient care [3][4] Company Overview - Baird Medical is a leading provider of minimally invasive MWA technology, focusing on advanced treatment solutions for conditions like thyroid nodules, breast disease, uterine fibroids, and liver cancer [4] - The company is publicly traded on NASDAQ and is dedicated to improving patient care through precision, efficiency, and safety in its medical devices [4]

As the largest independent microcap conference in the U.S., the 2025 Microcap Conference brought together over 750 institutional investors, venture capital representatives, and industry experts from around the world. This prestigious event provided Baird Medical with an exceptional platform to highlight its technological advancements and explore strategic opportunities. At the conference, Baird Medical demonstrated its cutting-edge minimally invasive microwave ablation technology, drawing significant attent ...

On October 2, 2024 (U.S. Eastern Time), Baird Medical successfully listed on the Nasdaq Stock Market, marking a significant milestone in its international growth strategy. This listing reinforces the Company's commitment to innovation, global market expansion, and enhancing shareholder value as it continues to pioneer cutting-edge medical solutions. PatentsIn 2024, Baird Medical further expanded its intellectual property portfolio, securing patents that enhance MWA technology and production efficiency: Inve ...